SCIENCEBRING   /   HAMBURG, GERMANY
International Journal of Advance Scientific Research SCIENTIFIC IDEAS. INTERNATIONAL PERSPECTIVES.
ISSN 2750-1396 12 issues per year · Monthly
Crossref DOI: 10.37547/ijasr

Search the Journal

Articles Published:

PRESERVING KIDNEY VITALITY: A HOLISTIC FRAMEWORK FOR MANAGING AND PREVENTING DRUG-INDUCED END-STAGE RENAL DISEASE

Vol. 3 No. 12 (2023): Volume 03 Issue 12 Pages 126-130
DOI 10.37547/ijasr-03-12-23 ↗
RESEARCH OVERVIEW

Abstract

This paper presents a comprehensive framework designed to preserve kidney vitality by effectively managing and preventing drug-induced end-stage renal disease (ESRD). With an increasing incidence of renal complications linked to pharmaceutical agents, a holistic approach is crucial. The proposed framework integrates medical, pharmacological, and lifestyle interventions, emphasizing early detection, risk mitigation, and patient education. By addressing both the underlying causes and proactive preventive measures, this approach aims to minimize the impact of drug-induced ESRD, promoting renal health and well-being.

Keywords

SOURCES & CITATIONS

References

Kellum JA, Levin N, Bouman C, Lameire N. Curr Opin Crit Care, 2002;8:509-514.
Mehta RL, Chertow GM. J Am Soc Nephrol, 2003; 14:2178-2187.
Whelton A. Am J Med, 1999; 106:13S-24S.
Han WK, Bailly V, Abichandani R. Kidney Int, 2002; 62:237-244.
Baliga R, Ueda N, Walker PD, Shah SV. Drug Metab Rev, 1999; 31:971-997.
Swan SK. Semin Nephrol, 1997; 17:27-33.
Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Semin Nephrol, 1997; 17:15-26.
Solomon R.. Kidney Int, 1998;53:230-242.
Murphy SW, Barrett BJ, Parfrey PS. J Am Soc Nephrol, 2000; 11:177-182.
Waybill MM, Waybill PN. JV asc Intervent Radiol, 2001; 12:3- 9.
Kintzel PE. Drug Saf, 2001; 24:19-38.
Mizumura Y, Matsumura Y, Hamaguchi T. Jpn J Cancer Res, 2001;92:328-336.
DISCOVER RELATED RESEARCH

Similar Articles

Continue exploring the collection ↗
11-20 of 166